A cultivation process development paradigm applied to the production of therapeutic proteins by glycoengineered yeast is presented. A combination of design of experiments, molecular profiling and metabolite analysis are employed in a systematic approach to enable establishment of a process fit for purpose for each of the drug development stages. This approach drives a fundamental understanding of the impact of process conditions on process consistency and product quality in a resource-efficient manner.